ALGS
Price
$10.80
Change
+$0.18 (+1.69%)
Updated
Sep 3 closing price
Capitalization
75.07M
IMNM
Price
$10.25
Change
+$0.97 (+10.45%)
Updated
Sep 3 closing price
Capitalization
893.95M
74 days until earnings call
Interact to see
Advertisement

ALGS vs IMNM

Header iconALGS vs IMNM Comparison
Open Charts ALGS vs IMNMBanner chart's image
Aligos Therapeutics
Price$10.80
Change+$0.18 (+1.69%)
Volume$23.68K
Capitalization75.07M
Immunome
Price$10.25
Change+$0.97 (+10.45%)
Volume$1.06M
Capitalization893.95M
ALGS vs IMNM Comparison Chart in %
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGS vs. IMNM commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a StrongBuy and IMNM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ALGS: $10.80 vs. IMNM: $10.25)
Brand notoriety: ALGS and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 31% vs. IMNM: 120%
Market capitalization -- ALGS: $75.07M vs. IMNM: $893.95M
ALGS [@Biotechnology] is valued at $75.07M. IMNM’s [@Biotechnology] market capitalization is $893.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, ALGS is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 6 TA indicator(s) are bullish while IMNM’s TA Score has 6 bullish TA indicator(s).

  • ALGS’s TA Score: 6 bullish, 4 bearish.
  • IMNM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than ALGS.

Price Growth

ALGS (@Biotechnology) experienced а -4.68% price change this week, while IMNM (@Biotechnology) price change was +3.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($894M) has a higher market cap than ALGS($75.1M). IMNM YTD gains are higher at: -3.484 vs. ALGS (-72.892). ALGS has higher annual earnings (EBITDA): -75.81M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. ALGS (123M). IMNM has less debt than ALGS: IMNM (4.14M) vs ALGS (6.88M). IMNM has higher revenues than ALGS: IMNM (12.6M) vs ALGS (3.17M).
ALGSIMNMALGS / IMNM
Capitalization75.1M894M8%
EBITDA-75.81M-187.92M40%
Gain YTD-72.892-3.4842,092%
P/E RatioN/AN/A-
Revenue3.17M12.6M25%
Total Cash123M268M46%
Total Debt6.88M4.14M166%
TECHNICAL ANALYSIS
Technical Analysis
ALGSIMNM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALGS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIGAX93.020.87
+0.94%
JPMorgan U.S. GARP Equity A
ADNAX19.950.08
+0.40%
American Beacon ARK Transfmt Innov A
FSEQX14.10N/A
N/A
Fidelity Advisor Sustainable U.S. Eq I
MTRIX20.01-0.02
-0.10%
MFS Total Return I
SCSRX19.57-0.05
-0.25%
Allspring Common Stock R6

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with XNCR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
+1.69%
XNCR - ALGS
43%
Loosely correlated
-2.57%
RLAY - ALGS
40%
Loosely correlated
+12.30%
CRNX - ALGS
36%
Loosely correlated
+4.05%
RZLT - ALGS
34%
Loosely correlated
+0.98%
IMNM - ALGS
34%
Loosely correlated
+10.45%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+10.45%
IDYA - IMNM
60%
Loosely correlated
+1.10%
DNTH - IMNM
55%
Loosely correlated
+1.72%
SYRE - IMNM
54%
Loosely correlated
+1.08%
RXRX - IMNM
53%
Loosely correlated
-0.64%
IPSC - IMNM
52%
Loosely correlated
-1.60%
More